Responses
Research Article
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
